Publicacións (331) Publicacións de José Castillo Sánchez

2024

  1. Differential blood-based biomarkers of subcortical and deep brain small vessel disease

    Therapeutic Advances in Neurological Disorders, Vol. 17

  2. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

    Journal of Cerebral Blood Flow and Metabolism

  3. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  4. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

2023

  1. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship

    Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454

  2. Perfusion-weighted software written in Python for DSC-MRI analysis

    Frontiers in Neuroinformatics, Vol. 17

  3. Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population

    Therapeutic Advances in Chronic Disease, Vol. 14

  4. Periodontitis is associated with subclinical cerebral and carotid atherosclerosis in hypertensive patients: A cross-sectional study

    Clinical Oral Investigations, Vol. 27, Núm. 7, pp. 3489-3498

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Antihyperthermic Treatment in the Management of Malignant Infarction of the Middle Cerebral Artery

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  3. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  4. Fibrin-Targeted Nanoparticles for Finding, Visualizing and Characterizing Blood Clots in Acute Ischemic Stroke

    Pharmaceutics, Vol. 14, Núm. 10

  5. Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  6. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  7. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  8. Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  9. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  10. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

  11. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  12. Treatments Against Glutamatergic Excitotoxicity in Ischemic Stroke

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 1-25